Navigation Links
Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
Date:4/28/2009

MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH) announced that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended March 31, 2009. The quarterly dividend will be payable May 22, 2009 to all common shareholders of record on May 8, 2009. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Techne's Board of Directors also authorized the repurchase of an additional $60 million of the Company's common stock in connection with its ongoing share repurchase program, which does not have an expiration date. Including the above amount, the total share repurchase authorization remaining is approximately $67.5 million. Repurchases under the program will be at the discretion of management and may be made in open market, pursuant to one or more 10b5-1 plans, structured transactions, privately negotiated transactions or otherwise, from time to time, depending on market conditions. The stock repurchase program may be modified or discontinued at any time. The share repurchase will be funded with a portion of the Company's existing cash and available-for-sale investments.

Techne Corporation has two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England. R&D Systems is a specialty manufacturer of biological products. R&D Systems has two subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. R&D China and R&D Europe distribute biotechnology products.

'/>"/>

SOURCE Techne Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Techne Corporation Announces Share Repurchase Authorization
2. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
3. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
4. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
5. Techne Corporation Declares Dividend
6. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
10. BioElectronics Corporation Announces Singapore and Malaysia Sales
11. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Research and Markets has ... Diagnostics Market (Product types, Application, Technology, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. This new report ... users and Geography) Global Size, Industry Analysis, Trends, ...
(Date:10/22/2014)... October 22, 2014 Involution Studios ... release of a new infographic, Understanding Ebola . ... a beautifully designed, easy to follow informative tool for ... of outbreak, symptoms and prevention. , "As the news ... the 2014 Ebola outbreak represents not only a healthcare ...
(Date:10/22/2014)... According to new market research report ... Integration, Deployment & Support), by Service Model (SaaS, ... Others (Hybrid & Community)) - Global Forecast to ... Cloud Professional Services Market into various sub-segments with ... also identifies the drivers and restraints for this ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
... June 29 The California Department of Labor today ... million grant to implement new workforce training programs for ... Initiative, a collaborative effort including CleanTECH San Diego, BIOCOM, San ... and the San Diego Workforce Partnership, captured the grant through ...
... SAN DIEGO , June 29 ... key commercialization milestones ahead of schedule. First, the company ... and commercial viability of a ,green, version of 1,4-butanediol ... confirmed the accelerated development time and reduced development and ...
... June 29, 2010 , , , ... it Will Carry the Disease and Therapy,Review: Impetigo Market Research Report in its Store. ... Browse the complete Report on:, http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im ,petigo/ , ... The Impetigo Disease and Therapy Review provides an overview ...
Cached Biology Technology:San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 2San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 3San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry 4Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 2Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 3Genomatica Delivers Pilot-Scale Validation in Sustainable Chemical Manufacturing 4Disease and Therapy Review: Impetigo Now Available at ReportsandReports 2Disease and Therapy Review: Impetigo Now Available at ReportsandReports 3Disease and Therapy Review: Impetigo Now Available at ReportsandReports 4Disease and Therapy Review: Impetigo Now Available at ReportsandReports 5
(Date:10/25/2014)... --  MedNet Solutions , a global life sciences technology ... to announce the 2014 iMedNet User Group ... in Bloomington, Minnesota on October ... and promises to be informative, productive and enjoyable for ... meeting is iMedNet™ EDC , MedNet,s ...
(Date:10/25/2014)... This report covers the specifics of microRNA ... heavy pursuit of research due to its versatility and ... other RNA components. miRNA,s non-coding nature and ability to ... use as a biomarker for a variety of diseases. ... for the advancement in therapeutic development. Furthermore there are ...
(Date:10/25/2014)... -- A recent report, "Genetic Testing Market Outlook 2018", ... genetic testing market. A comprehensive introduction of gene-based tests, ... report. On account of our analysis of the past ... challenges; forecast for genetic testing has been drawn, according ... a CAGR of around 9% during 2013-2018. Our ...
Breaking Biology News(10 mins):MedNet Solutions To Host Third Annual iMedNet User Group Meeting 2MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Genetic Testing Market Outlook 2018 2
... Scientists at St. Jude Children's Research Hospital have announced ... against one antigenic variant of the avian influenza virus ... virus. Vaccines based on this model might therefore be ... epidemic) until a new vaccine could be developed specifically ...
... half of human cancers involve mutations in the p53 ... normal p53 protein in defending against cancer. Similarly, roughly ... occur in its DNA-binding core domain, pointing to this ... its anti-cancer activity. , Clearly, a detailed view of ...
... a lifetime of daily injections to replace the ... as a host of risks that includes blindness, ... particularly those afflicted with juvenile diabetes, transplants of ... might alleviate these problems. Unfortunately, there are not ...
Cached Biology News:Scientists to employ Arctic ice and polar bears to protect diversity of world's crops 2Structure determined for p53 tumor suppressor protein as bound to DNA for anti-cancer activity 2Successful transplantation from pig embryos to mice 2
... I can be used in intracellular staining ... cells and to serve as an antibody ... cell permeabilization is a reversible process, it ... the presence of saponin during intracellular staining. ...
... raised against a partial recombinant ... PPP4C (NP_002711, 218 a.a. ... protein with GST tag. ... NM_002720 Protein ...
... Eppendorf Thermomixer R offers maximum application ... shaking, heating, and cooling. Its active ... application and temperature control ranges. Five ... 24 micro test tubes, are available ...
Mouse monoclonal antibody raised against a partial recombinant PDE2A. NCBI Entrez Gene ID = PDE2A...
Biology Products: